Showing results (11-20 of 210) with videos related to
Sort By:
Pageof 21
Frontiers in Immunology|September 12, 2022
Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancementsChae-Ok Yun, JinWoo Hong, A-Rum YoonOncotarget|November 5, 2017
Adenovirus-mediated decorin expression induces cancer cell death through activation of p53 and mitochondrial apoptosisA-Rum Yoon, JinWoo Hong, Chae-Ok YunOncotarget|November 9, 2016
Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacyHyo Min Ahn, JinWoo Hong, Chae-Ok YunOncotarget|December 22, 2016
Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor modelEonju Oh, Il-Kyu Choi, JinWoo Hong, et al.Scientific Reports|February 4, 2018
Hepatocellular carcinoma-targeting oncolytic adenovirus overcomes hypoxic tumor microenvironment and effectively disperses through both central and peripheral tumor regionsA-Rum Yoon, JinWoo Hong, Minjung Kim, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|June 25, 2011
Viral genome DNA/lipoplexes elicit in situ oncolytic viral replication and potent antitumor efficacy via systemic deliveryOh-Joon Kwon, Eunah Kang, Sungwan Kim, et al.Cancer Gene Therapy|April 21, 2022
Challenges and progress toward tumor-targeted therapy by systemic delivery of polymer-complexed oncolytic adenovirusesThavasyappan Thambi, JinWoo Hong, A-Rum Yoon, et al.Scientific Reports|January 25, 2018
A hypoxia- and telomerase-responsive oncolytic adenovirus expressing secretable trimeric TRAIL triggers tumour-specific apoptosis and promotes viral dispersion in TRAIL-resistant glioblastomaEonju Oh, JinWoo Hong, Oh-Joon Kwon, et al.Mathematical Biosciences and Engineering : MBE|January 19, 2016
Application of ecological and mathematical theory to cancer: New challengesYangjin Kim, Avner Friedman, Eugene Kashdan, et al.Frontiers in Cell and Developmental Biology|July 21, 2022
Why is Mortalin a Potential Therapeutic Target for Cancer?A-Rum Yoon, Renu Wadhwa, Sunil C Kaul, et al.Pageof 21